“During the 2020s, AI plus biotechnology will cure most chronic degenerative diseases”【24†L169-L174】
No checked 2024 passage supports this exact cure-most-chronic-disease wording/deadline. Earlier biomedical optimism is not a substitute.
Attribution unresolved — outcome conditional on this wording
AI and biotechnology cure most chronic degenerative diseases during the 2020s.
Conditional verdict: PENDING
At original deadline: NOT DUE · By review: PARTLY FULFILLED
The decade is not over. Mechanistic and genomic research represents progress, not evidence that most conditions are cured. This imported attribution needs its original passage; current progress can nevertheless be assessed.
Excluded from aggregate author accuracy. Conditional wording and related canonical versions are never counted twice.
N38N39N40O17Disposition sources:
The original imported lead.
“During the 2020s, AI plus biotechnology will cure most chronic degenerative diseases”【24†L169-L174】
2024 · Attribution / year unconfirmed
Page, edition, or timestamp not yet established
- Normalized claim
- Not established. The testable claim will be written after the original wording is checked.
- Success criteria
- Not established. Thresholds, adoption requirements, geography, cost, and required technology must be retained during review.
- Claim type
- Not classified
Timeline
Supplied target wording: 2020s. No confirmed date is used in calculations. Forecast horizon: not established. Drift is a calendar-year difference, not a precise elapsed duration.
The evidence.
No outcome evidence has been verified.
Legacy ratings are preserved in the source package. They have not been accepted as evidence for this assessment.
Capability, adoption, and timing
A related breakthrough is not automatically fulfillment. Review must check the actual capability, how widely it was required to be used, the specified technology, and the original deadline. A prototype cannot establish a claim about routine or widespread use.
Research notes & history
Imported research lead only. Verify attribution, deadline, scope and outcome; do not inherit the legacy score. Draft category needs review.
Open questions
- Check the original wording, attribution, and publication date.
- Establish the deadline and full success criteria.
- Resolve repetitions and related forecast versions.
- Find independent evidence for the deadline and review outcomes.
- Imported from
- kurzweil_prediction_intake_v0_1.csv · CSV row 85
- Legacy identifier
- EXE-025
- Forecast family
- Not assigned
- Parent statement
- EXE-025
- File checksum
- dcf2f213917bfaccdcdd45a7b98b5db4243cda090687358879d5ed53838f3bb2
Inspect preserved source fields
- Record ID
- EXE-025
- Prediction — imported lead
- “During the 2020s, AI plus biotechnology will cure most chronic degenerative diseases”【24†L169-L174】
- Primary category — draft
- Biology & medicine
- Subcategory / secondary tags
- Biotech / AI
- Claimed source — legacy
- *Singularity Is Nearer* (2024)
- Source year — unconfirmed
- 2024
- Target text — legacy
- 2020s
- Confirmed deadline year
- (blank)
- At-deadline outcome
- UNREVIEWED
- Outcome at review
- UNREVIEWED
- First full-achievement year
- (blank)
- Review year
- 2026
- Review state
- UNREVIEWED
- Canonical for statistics?
- NO
- Forecast family ID
- (blank)
- Parent statement ID
- EXE-025
- Prediction source URL
- (blank)
- Page / paragraph / timestamp
- (blank)
- Outcome evidence URLs
- (blank)
- Success criteria / scope
- (blank)
- Original wording checked?
- NO
- Adoption stage / claim type
- (blank)
- Date precision / target interval
- (blank)
- Review notes
- Imported research lead only. Verify attribution, deadline, scope and outcome; do not inherit the legacy score. Draft category needs review.
- Legacy import ID
- EXE-025
- Display status
- UNREVIEWED
- Drift — years
- (blank)
- Overdue — years
- (blank)
- Due and eligible
- 0
- On-time full hit
- 0
- Full realization hit
- 0
- Publication year confirmed
- (blank)
Review history
— Evidence v0.2: No checked 2024 passage supports this exact cure-most-chronic-disease wording/deadline. Earlier biomedical optimism is not a substitute.
— QUARANTINE_UNLOCATED_ATTRIBUTION: No checked 2024 passage supports this exact cure-most-chronic-disease wording/deadline. Earlier biomedical optimism is not a substitute. Original record retained; no automatic redirect or score inherited.
Related forecasts.
No forecast family has been resolved for this record. Related statements and revised deadlines will be linked during research.